Lakefront Biotherapeutics | GLPG - Trade Debtors


Lakefront Biotherapeutics reported EUR54.03M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
argenx SE USD 2.01B 352.94M Jun/2026
AstraZeneca USD 18.86B 972M Jun/2026
Biogen USD 1.79B 76.6M Mar/2026
Genmab DKK 1.22B 192M Jun/2026
Gilead Sciences USD 5.06B 314M Jun/2026
GlaxoSmithKline GBP 8.07B 137M Jun/2026
GRIFOLS EUR 1.19B 231M Jun/2026
Hikma Pharmaceutical USD 1.08B 27M Dec/2025
Incyte USD 1.13B 73.7M Jun/2026
Merck EUR 4.81B 373M Mar/2026
Neurocrine Biosciences USD 887M 118.9M Jun/2026
Novartis USD 9.85B 252M Jun/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
Sanofi EUR 492M 10M Jun/2026
UCB EUR 1.97B 54M Dec/2025
Vertex Pharmaceuticals USD 2.13B 138.2M Jun/2026